- Report
- November 2026
- 377 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 389 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 191 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 376 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 282 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 108 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 474 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- November 2026
- 732 Pages
Global
From €5502EUR$5,850USD£4,590GBP
- Report
- July 2026
- 154 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- June 2026
- 180 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- May 2026
- 140 Pages
Global
From €4467EUR$4,750USD£3,727GBP
- Report
- July 2026
- 150 Pages
Global
From €3527EUR$3,750USD£2,942GBP
- Report
- August 2026
- 176 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 180 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 183 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 181 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 178 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 170 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 180 Pages
Global
From €3715EUR$3,950USD£3,099GBP
- Report
- August 2026
- 176 Pages
Global
From €3715EUR$3,950USD£3,099GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more